Related Experiment Video
Updated: Aug 13, 2025

Author Spotlight: Dendritic Cells Maturation Using Sialidases-Based Enzymatic Treatment of the Cell Surface
Published on: October 20, 2023
The (Sialyl) Tn antigen: Contributions to immunosuppression in gastrointestinal cancers
Christabelle Rajesh1, Prakash Radhakrishnan1
1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, United States.
Abstract:
Cellular signaling pathways are intricately regulated to maintain homeostasis. During cancer progression, these mechanisms are manipulated to become harmful. O-glycosylation, a crucial post-translational modification, is one such pathway that can lead to multiple isoforms of glycoproteins. The Tn (GalNAc-O-Ser/Thr) and Sialyl Tn (STn; Neu5Ac-GalNAc-O-Ser/Thr) antigens resulting from the incomplete synthesis of fully branched O-glycan chains on proteins contribute to disease progression in the pancreas and other gastrointestinal cancers. The tumor microenvironment (TME) is a major constituent of tumors and a key modulator of their behavior. Multiple cellular and secretory components of the TME dictate the development and metastasis of tumors. Immune cells like macrophages, natural killer (NK) cells, dendritic cells, B and T lymphocytes are a part of the tumor "immune" microenvironment (TIME). The expression of the Tn and STn antigens on tumors has been found to regulate the function of these immune cells and alter their normal antitumor cytotoxic role. This is possible through multiple cell intrinsic and extrinsic signaling pathways, elaborated in this review. Studying the interaction between Tn/STn antigens and the TIME of gastrointestinal cancers can help develop better and more robust therapies that can counteract immunosuppressive mechanisms to sensitize these tumors to anticancer therapies.
Insights
Cancer cells manipulate O-glycosylation, producing Tn and Sialyl Tn (STn) antigens. These antigens disrupt the tumor immune microenvironment (TIME), hindering anti-cancer immune responses in gastrointestinal cancers.
Area of Science:
- Biochemistry and Molecular Biology
- Immunology
- Oncology
Background:
- Cellular signaling pathways are critical for homeostasis but are often dysregulated in cancer.
- O-glycosylation, a post-translational modification, generates glycoproteins, including Tn and Sialyl Tn (STn) antigens, implicated in pancreatic and gastrointestinal cancers.
- The tumor microenvironment (TME), comprising immune cells and other components, significantly influences tumor progression and metastasis.
Purpose of the Study:
- To review the role of Tn and STn antigens in cancer progression.
- To elucidate how Tn and STn antigens modulate the tumor immune microenvironment (TIME).
- To explore potential therapeutic strategies targeting the interaction between Tn/STn antigens and the TIME.
Main Methods:
- Literature review of studies on O-glycosylation, Tn/STn antigens, and the tumor microenvironment in gastrointestinal cancers.
- Analysis of signaling pathways involved in the interaction between tumor antigens and immune cells.
- Synthesis of current understanding of immunosuppressive mechanisms mediated by Tn/STn antigens.
Main Results:
- Tn and STn antigens, resulting from incomplete O-glycosylation, are associated with disease progression in gastrointestinal cancers.
- Expression of Tn/STn antigens on tumors alters the function of immune cells within the TIME, suppressing anti-tumor activity.
- These antigens mediate immunosuppression through various cell-intrinsic and extrinsic signaling pathways.
Conclusions:
- The interaction between Tn/STn antigens and the TIME is a key factor in the progression of gastrointestinal cancers.
- Targeting these interactions offers a promising avenue for developing novel cancer therapies.
- Understanding these mechanisms can help overcome immunosuppression and sensitize tumors to existing treatments.
Related Concept Videos
Tumor Immunotherapy
Cell-mediated Immune Responses
The Tumor Microenvironment

